Ryman’s turnaround is well under way: Forsyth Barr

Ryman’s turnaround is well under way: Forsyth Barr
Forsyth Barr's Aaron Ibbotson rates Ryman shares as "outperform". (Image: Forsyth Barr)
Jenny Ruth
Forsyth Barr analyst Aaron Ibbotson has taken a deep dive into Ryman Healthcare‘s debt position and its turnaround strategy and concluded it is “changing its stripes more than the market is giving it credit for”.The market has certainly exhibited extreme disillusion with the stock in recent weeks.Ryman shares fell as low as $4.82 after it completed its $902 million capital raising, compared with the rights issue price of $5 per new share and $6.40 before the mid-February announcement.The shares closed at $5.22 on Tuesday.A goo...

More Markets

NZ sharemarket up 0.4% despite inflation report
Markets Market Close

NZ sharemarket up 0.4% despite inflation report

The S&P/NZX 50 Index closed at 13,344.96, up 55.75 points or 0.42%.

What Infratil likes about Contact Energy
Infrastructure

What Infratil likes about Contact Energy

Infratil is keeping its options open, while TECT diversifies.

Disclosure breaches Class action against ANZ NZ continues
Finance

Disclosure breaches Class action against ANZ NZ continues

It comes as retrospective law tweaks fail to give relief.

Kiwi Capital Limited appoints Susan Peterson as chair
Finance

Kiwi Capital Limited appoints Susan Peterson as chair

New chair of Kiwibank parent company Kiwi Capital Ltd brings breadth of experience.